Related Experiment Video
Updated: Mar 18, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Riser pattern is a predictor of kidney mortality among patients with chronic kidney disease
Kentaro Nakai1, Hideki Fujii1, Kentaro Watanabe1
1a Division of Nephrology and Kidney Center , Kobe University Graduate School of Medicine , Kobe , Japan.
Insights
In chronic kidney disease (CKD) patients, a rising blood pressure (BP) pattern overnight, known as the riser pattern, is linked to worse kidney survival. This risk is amplified in patients with elevated brain natriuretic peptide (BNP) levels.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Background:
- Hypertension is a major risk factor for cardiovascular mortality and loss of kidney function.
- The absence of a normal nocturnal blood pressure (BP) decline indicates poor prognosis.
- Characteristics of hypertension in moderate-to-severe chronic kidney disease (CKD) require further evaluation.
Purpose of the Study:
- To assess the circadian variation of BP in CKD patients.
- To evaluate the impact of BP circadian rhythm on kidney survival.
- To determine the role of brain natriuretic peptide (BNP) in kidney prognosis.
Main Methods:
- 124 patients with moderate-to-severe CKD (eGFR <45 ml/min/1.73 m²) were enrolled.
- 24-hour ambulatory BP monitoring (ABPM) was used to assess BP circadian patterns.
- The association between BP patterns, BNP levels, and kidney survival was analyzed.
Main Results:
- 45% of patients exhibited a non-dipper BP pattern, 35% a riser pattern, and 19% a dipper pattern.
- The riser-pattern group had higher prevalence of diabetes, elevated BNP, and lower eGFR compared to non-risers.
- Kidney survival was significantly worse in the riser-pattern group, especially those with higher BNP levels.
Conclusions:
- The riser BP pattern is common in CKD and associated with increased risk for kidney survival.
- CKD patients with a riser BP pattern and elevated BNP levels face a poorer kidney prognosis.
- Circadian BP variations, particularly the riser pattern, are critical markers for kidney health in CKD.
Background:
Hypertension is a crucial risk factor for cardiovascular death and loss of residual kidney function. Absence of the nocturnal decline in blood pressure (BP) predicts cardiovascular events and poor prognosis. However, characteristics of hypertension in moderate-to-severe chronic kidney disease (CKD) have not been fully evaluated. We aimed to assess the circadian variation of BP and kidney survival in CKD patients.
Methods:
Patients who were examined by 24-h ambulatory BP monitoring (ABPM) and estimated glomerular filtration rate (eGFR), <45 ml/min/1.73 m(2), were enrolled in the study. The impacts of BP circadian rhythm and brain natriuretic peptide (BNP) on kidney survival were evaluated.
Results:
A total of 124 patients were enrolled. The average age was 64 ± 14 years, 57% were male, and 43% had diabetes. Forty-five percent of patients had a non-dipper pattern, 35% had a riser pattern, 19% had a dipper pattern, and 1% had an extreme-dipper pattern. The prevalence of diabetes and plasma BNP levels was higher and eGFR was lower in the riser-pattern group than in the non-riser-pattern group. Kidney survival rates were significantly worse in the riser-pattern group than in the non-riser-pattern group (p < 0.05). Moreover, among riser and non-riser pattern groups divided by BNP levels, the riser group with higher BNP level showed the worst kidney survival (p < 0.05).
Conclusion:
The riser pattern is frequently associated with several conditions at higher risk for kidney survival. Patients with a rising pattern and higher BNP levels have a worse kidney prognosis.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations

